George Matcham
Director/Board Member bei INSTIL BIO, INC.
Vermögen: 19 586 $ am 31.03.2024
Profil
George Matcham currently works at Instil Bio, Inc., as Independent Director from 2018.
Dr. Matcham also formerly worked at Chimeric Therapeutics Ltd.
(Australia), as Non-Executive Director from 2021 to 2023, Celgene Corp., as SVP-CAR T CMC & Technology Development from 2017 to 2018, and Celgene Cellular Therapeutics, as Chief Operating Officer.
Dr. Matcham received his graduate degree from the University of Cambridge and undergraduate degree and doctorate degree from the University of Cardiff.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.09.2023 | 1 000 800 ( 0,12% ) | 19 586 $ | 31.03.2024 | |
INSTIL BIO, INC.
-.--% | 14.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von George Matcham
| Unternehmen | Position | Beginn |
|---|---|---|
| INSTIL BIO, INC. | Director/Board Member | 01.09.2018 |
Ehemalige bekannte Positionen von George Matcham
| Unternehmen | Position | Ende |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Director/Board Member | 03.08.2023 |
| CELGENE | Corporate Officer/Principal | 01.06.2018 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Chief Operating Officer | - |
Ausbildung von George Matcham
| University of Cambridge | Graduate Degree |
| University of Cardiff | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The private company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
| Instil Bio, Inc. |
